Biotech Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-‘567 in Adults with Alzheimer’s Disease October 20, 2026
Biotech Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing October 20, 2026
Biotech A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday October 20, 2026
Biotech TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS October 20, 2026
Biotech Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study October 20, 2026
Biotech Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season October 20, 2026
Biotech Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer October 20, 2026
Biotech Penumbra’s CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT) October 20, 2026
Biotech Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum October 20, 2026
Biotech IDEAYA Biosciences Announces London Investor R&D Day and Participation in Upcoming September 2026 Investor Conferences September 1, 2026